chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Full body rash. It began at the bottom of her back and then went up her entire back to the sides of her neck. Then over the tops of her shoulders and around her sides onto her breasts and into her underarm area.; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 16Mar2021 at 12:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient had other medical history (unspecified). The patient had known allergies (unspecified). The patient taken other medications (unspecified) within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021, the patient experienced full body rash. It began at the bottom of her back and then went up entire back to the sides of neck. Then over the tops of her shoulders and around sides onto her breasts and into underarm area. It was then on her abdomen and upper thighs and groin area as well as buttocks and back of her legs. Arms also had rash on inner elbow area. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with Betamethasone Dipropionate Cream USP 0.05%. The clinical outcome of the event full body rash. It began at the bottom of her back and then went up entire back to the sides of neck. Then over the tops of her shoulders and around sides onto her breasts and into underarm area. It was then on her abdomen and upper thighs and groin area as well as buttocks and back of her legs. Arms also had rash on inner elbow area was not resolved. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ED7534) via an unspecified route of administration in the left arm on 06Apr2021 at 12:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Presented to hospital 4/23/09 with reported edema - redness and tenderness of left deltoid. Treated with KEFLEX 250 mg TidX7days. 4/27/09 only site of injection noticeable.
Information has been received from a physician concerning a 9 year old male on 21-MAR-2001, and 29-JUL-2004 was vaccinated with the first and second dose of MMR II respectively (route, site, and lot number not reported). On 25-DEC-2009 the patient experienced mumps (the date diagnosed was reported as 18-NOV-2009). The patient also experienced sore throat and was afebrile. On 18-NOV-2009, the first blood work was done which revealed serum IgM <1:10, serum IgG 2.27, and serum amylase 352. The outcome for mumps was not reported. Follow up information has been received from the physician concerning the 9 year old (also reported as 7 year old) male patient who on 13-JAN-2010 developed and was diagnosed with mumps. The patient developed right parotitis. The patient's body temperature was 103 degrees F. On 13-JAN-2010, the first blood work was done which reveled serum IgM <1:10, serum IgG 6.22, and serum amylase 263. At the time of the report, the outcome of the patient was unknown. No further information is available.
Minimally responsive; Severe left arm pain; systemic weakness and lethargy resulting in 5 falls within the week after the shot; systemic weakness and lethargy resulting in 5 falls within the week after the shot; systemic weakness and lethargy resulting in 5 falls within the week after the shot; This is a spontaneous report from a contactable nurse. An 86-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 86-year-old, via an unspecified route of administration, administered in left arm on 24Mar2021 (Lot Number: ER2613) as single dose for COVID-19 immunisation. Medical history included cerebrovascular disease, HTN, DMII, dementia. Concomitant medications included metformin, glimepiride, amlodipine, acetylsalicylic acid (ASPIRIN (E.C.)), senna alexandrina leaf, and vitamin D. The patient was not diagnosed with COVID-19 prior vaccination and was not tested post vaccination. The patient has no known allergies. The patient was previously vaccinated with the first dose of BNT162B2 (lot number: EN6206) at the age of 86-year-old, on 03Mar2021 11:00 AM, intramuscular at the left arm for COVID-19 immunisation. On 25Mar2021 06:00 AM, the patient experienced severe left arm pain, systemic weakness and lethargy. This resulted in 5 falls within the week after the shot on 24Mar2021. Minimally responsive on 05Apr2021 and transferred with full assist to hospital bed. Gathered family for goodbyes on 06Apr2021 as appeared terminal. On 07Apr2021 some alertness in afternoon and strength has been slowly improving as of today 12Apr2021. No treatment was received for the events. The patient was hospitalized due to the event minimally responsive on 05Apr2021. The outcome of the events was recovering.; Sender's Comments: Based on the available information, the Company considers the reported event minimally responsive is unrelated to BNT162B2 vaccination but more likely an inter-current medical condition in this 86-year-old male patient with medical history of cerebrovascular disease, HTN, DMII, dementia. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
A spontaneous report was received on 12-JUL-2016 from a healthcare worker regarding a female patient (age not reported). On 12-JUL-2016 the patient was inadvertently administered an expired dose of PNEUMOVAX 23 (lot # L007720, expiration 07-JUL-2016). No adverse effect was reported. No further details were provided. Additional information has been requested.
in the last month I think it acts for the probably once every 4 or 5 days during the night; its kind of like an irregular type of heart beat; these sweaters that I have been having thats increased; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received bnt162b2 (Pfizer Covid 19 Vaccine, formulation: solution for injection, Lot Number: EW0173), via an unspecified route of administration on an unspecified date 1ST DOSE, SINGLE for covid-19 immunisation. Medical history included palpitations, patient had some heart palpitations that has been going on for many years. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced in the last month i think it acts for the probably once every 4 or 5 days during the night, its kind of like an irregular type of heart beat, these sweaters that i have been having that increased. The patient had first shot about four weeks ago and couple of three days ago. The patient had some heart palpitations that been going on for many years and usually they are, they will acts up during at night once every, every two or three months and in the last month I think it acts for the probably once every 4 or 5 days during the night and it goes away and then four five days again it acts up again. The patient thought this kind of interesting that had been doing this scenario since the patient got shot and then couple of days ago, it acted up at night and the next day it acted up at night So, the patient went to setup an appointment with cardiologist to kind of find out what's going on because these sweaters that he have been having that's increased and so he had an appointment with a Heart Specialist here next Friday. The patient further reported that "I don't necessarily not necessarily saying that the Pfizer drug increased this, but it is interesting that after I, my wife and I both had the shots about a month ago, it's kind of interesting that we do heart palpitations in (Split not made), when I was having heart palpitations every one or two months over certain every four five days I would have during the night and they would wait four five days have another one and it's like it's kind of interesting and I don't know if it's any correlation with drug at all, may just be a coincidence that my understanding have more these palpitations (further not clarified) and but I thought today when my wife went to get her 2nd shot they were wondering where I was and she said well this is the situation with my husband and they said well, if you would have, if your husband call this number and just kind a report what's going on whether it's perhaps directly related with it or not, I don't know may be my heart specialist when I see him next Friday even may have a little more of idea of this problem before, if it's covid vaccine drug but anyway I just, they told me to go ahead and call this number and let you know of it". The outcome of the events was unknown.  Information on Lot/Batch number was available. Additional information has been requested.
Fever and swelling at injection site. 6" raised wheal around injection site. No drainage
Severe lower back pain; This is a spontaneous report from a contactable consumer, the patient. A 36-years-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 20Mar2021 at 10:15 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patients medical history included mitral valve prolapse on an unspecified date. Concomitant medications included Citalopram (MANUFACTURER UNKNOWN) 25 mg daily started on an unknown date for unknown indication. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no allergies to medications, food, or other products.  The patient experienced severe lower back pain on 21Mar2021 at 08:00. The patient did not receive any treatment for the event.   Clinical outcome of the severe lower back pain was recovering.  Information about lot/batch number cannot be obtained. No further information expected.
Redness, lots of swelling in left deltoid, pain in arm and up left side of face, left eye swollen
pt recvd vax & 12-16 hrs later exp a localized neck rash w/o itching; 3-4 days pt's family MD instructed pt to discontinue series;
Hives on arm and shoulder 10 minutes after vaccination.  Benadryl was given and hives started to improve within 20 minutes.  No anaphylaxis.
Information has been received from a registered nurse concerning a patient that was over age 65 who on an unspecified date was vaccinated with the first dose of PNEUMOVAX 23 (Lot# either 663889/0632Y or 665924/0930Z). It was reported that on an unspecified date, the patient experienced a local site reaction (redness, swelling, and pain). The nurse reported that the patient received either dexamethasone (MSD) or dexamethasone (manufacturer unknown) as treatment (thought to be an allergic reaction). On an unspecified date, the patient recovered. It was unknown if the patient sought medical attention. This is one of several reports received from the same source. The health care professional contacted during telephone follow up could not supply the following information: patient names, dates of birth, dates of vaccination, lot number and dates of events. Additional information has been requested.
Very fatigued that evening three and a half hours after the shot. Woke up still fatigued in the morning with slight fever and slight nausea and with a headache and with a foggy feeling in my brain.That lasted all day on the 28th. I left work and slept and rested a lot. By the next morning on the 29th I felt pretty much back to normal.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 22-AUG-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (strength: 0.5ml, lot # K005957, expiration date 08-MAR-2015, route unspecified). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 1728 hours with lowest recorded temperature of 20 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
flu; HR was higher than normal; fever; felt weak; dry cough; headache; muscle and joint pains; muscle and joint pains; This is a spontaneous report from a contactable nurse.  A 27-year-old female patient received the second dose of bnt162b2, intramuscular in the left arm, from 12Jan2021 09:00 at SINGLE DOSE for covid-19 immunization. Patient was not pregnant at vaccination. Medical history included GERD (gastroesophageal reflux disease) and barrett's esophagus. Historical Vaccine included 1st dose of BNT162B2 on 24Dec2020 via intramuscular in the right arm for COVID-19 immunization. Concomitant medications included melatonin, pantoprazole sodium sesquihydrate (PROTONIX), calcium carbonate, magnesium carbonate, magnesium trisilicate (TUMS), and algeldrate, alginic acid, magnesium trisilicate, sodium bicarbonate (GAVISCON). On 13Jan2021 03:00, the patient felt like she had a flu; her HR was higher than normal, felt like she had a fever, felt weak, developed a dry cough, headache; and muscle and joint pains. The outcome of events was recovered. The patient did not receive any treatment for the events.  Information on the lot/batch number has been requested.
next morning after shot,  extreme lethargy and body and head ache pains, which persisted thru day and elevated during evening hours.
This case was reported by a other health professional via call center representative and described the occurrence of rash in a 46-year-old male patient who received RABAVERT (batch number 596011A, expiry date December 2018). The patient's past medical history included bit (On 15th August 2016 the patient had a bite). Concomitant products included DTPA (Reduced antigen), (DTPA vaccine), Rabies NVS (Rabies Vaccine, Rabies NVS (Rabies Vaccine) and Rabies NVS (rabies Vaccine). On 21st August 2016, the patient received the 1st dose of RABAVERT 1 ml. On 22nd August 2016, 1 days after receiving RABAVERT, the patient experienced rash. On an unknown date, the outcome of the rash was recovering/resolving. The reporter considered the rash to be possibly related to RABAVERT. Additional details were provided as follows: This case was previously reported to a doctor. The patient had received 3 doses of unknown manufacturer rabies vaccine given approximately 1 month before bite. The patient experienced rash on chest after receiving a dose of RABAVERT for post exposure series. The reporter stated that urgent care visit was required. No Patient or product information was available at the time of the report. The patient's doctor would call with additional details of event.
Hot at shot site, fever, swelling, redness, hives, red streaks coming out of center for about 1 to 2 inches (4 to 6 of them) - hospital said infection flowing thru veins, arm hurt, couldn't raise arm up, shot site extremely painful.
I experienced vomiting, chills, nausea, which lasted for 30 minutes before my wife took me to the ER. All tests were normal, but I came home with body aches, joint pain, diarrhea, and vomiting returned when the anti nausea meds ran out. Doctor was seen the next day and stated it could be a delayed reaction to the vaccine. My symptoms lasted all of that month and have returned on and off since that day. Have since had 2 hospital visits due to this.
Progress Notes Healthcare Provider  Healthcare Facility 3/15/2021    Patient                                                                        Date:  3/15/2021                                                                                              Subjecti Patient is a 31 y.o. male who was seen at healthcare facility today for his first  dose of the COVID 19 vaccination.    He was given the Pfizer vaccination in the right deltoid muscle.   During his 15 minute waiting period after the injection, the patient began to experience throat tightness.  He denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, hoarseness, stridor, itching, lightheadedness, dizziness, facial swelling, lip swelling and tongue swelling.   This provider was notified of patient reaction and he was then assessed.   Monitored patient for severe reaction symptoms, including but not limited to blood pressure abnormality , hypotension, rapid progression of symptoms, respiratory distress and tongue swelling.    Past Medical History: Diagnosis Date ? Eczema   ? Morbid obesity with BMI of 40.0-44.9, adult (HCC)   ? Seasonal allergies       ALLERGY REVIEW OF SYSTEMS:  Patient denies chills, fever, malaise/fatigue, facial swelling, sore throat, frequent throat clearing, cough, chest tightness, shortness of breath, wheezing, rash, hives, eczema, itching of skin, vomiting, abdominal pain, dizziness and headaches       Previous Reactions: none to vaccines    Objective    Vitals Vitals:   03/15/21 1520 03/15/21 1528 BP: (!) 149/98 (!) 140/88 Pulse: 80 72 SpO2: 100% 100%        Physical Exam Vitals reviewed.  Constitutional:      General: He is not in acute distress.    Appearance: He is not ill-appearing or diaphoretic.  HENT:     Mouth/Throat:     Mouth: Mucous membranes are moist.     Pharynx: Oropharynx is clear.     Comments: Clear oropharynx. Eyes:     Conjunctiva/sclera: Conjunctivae normal.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.     Heart sounds: Normal heart sounds.  Pulmonary:     Effort: Pulmonary effort is normal.     Breath sounds: Normal breath sounds and air entry.     Comments: Speaking full sentences. No throat clearing Skin:    General: Skin is warm.     Coloration: Skin is not pale.     Findings: No rash.  Neurological:     General: No focal deficit present.     Mental Status: He is alert and oriented to person, place, and time.  Psychiatric:        Mood and Affect: Mood normal.        Thought Content: Thought content normal.        Judgment: Judgment normal.         Assessment/Plan  Treatment included: water Follow up response to treatment: excellent. Patient discharge: Stable to go home and follow up with PCP.  Differential Diagnosis: Vaccine-Related Anxiety (include misc mental health)   Pt admits he was anxious prior to coming in today and felt anxious while he was in line for registration. He feels better after being evaluated here. He was observed for approx. 15 minutes. He requests to be here for his #2 pfizer vaccine. Request is reasonable.  Registration notified and will flag his chart for next time.    Healthcare Provider
This spontaneous report was received from a physician regarding a 4 year old patient of unknown gender. The patient's relevant medical history, concurrent conditions and concomitant medications were not reported. On 29-SEP-2016, the patient was vaccinated with PROQUAD (dose, route and frequency were not reported) lot# M015700 with expiration date 26-SEP-2017 for prophylaxis when refrigerator was out of range (Incorrect product storage). This is one of the several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA004566: US-009507513-1701USA004717: US-009507513-1701USA004718: US-009507513-1701USA004719: US-009507513-1701USA004720: US-009507513-1701USA004721: US-009507513-1701USA004722: US-009507513-1701USA004723: US-009507513-1701USA004724: US-009507513-1701USA004726.
Soreness started day of shot.  Arm sore when reaching for seat-belt or putting on coat.
Nasal congestion; shaking chills; Momentary feeling of a lot of heat; sweat; burning throat; No menstrual period; Cough; This is a spontaneous report from a contactable consumer or other health care professional (patient). A 37-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EW0177) via an unspecified route of administration, administered in Arm Left on 12May2021 19:30 (at the age of 37 years old) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had tested for COVID-19. The patient did not receive any other vaccines within four weeks and within 2 weeks of vaccination. On 15May2021 10:00am, the patient experienced shaking chills, momentary feeling of a lot of heat, sweat, cough, nasal congestion, burning throat and no menstrual period. The patient was treated with Tylenol Flu, Antibiotic for the adverse events caused. The patient underwent lab tests and procedures which included oral swab test results negative on 25May2021. The clinical outcome of the events was recovered with sequelae on an unspecified date in May2021.  Follow up attempts are needed. Further information has been requested.
Had PREVNAR Vaccine - adverse reaction, red and inflamed at injection site. Very swollen at the injection site. Pt felt fatigued. Was not able to move arm.
Mother complained that baby vomiting from 02/24/09 to present, and fever fora day.tynelol given for fever ,fluids pedalite for vomiting.
arm became swollen;early abscess formation occurred;ax lymph node was swollen to 2x2cm & supraclavicular node was 1x1cm;t103 & adm to hosp;few days later fever persisted;dx lymphadenopathy/fever;affected area indurated;elevated WBC;
Immunization received on Friday, fever and chills on Saturday all throughout the day, took Tylenol to manage symptoms. Sinus pressure, tenderness in neck. Restlessness. Patient states feeling "Kind of in a fog."  Patient took 50mg Benadryl on Monday. Hives started on Wednesday morning. Counseled patient on vsafe.cdc.gov resources. Recommended to go to doctor for allergic reaction management such as for steroid therapy.
3 days after the vaccination, I developed tingling of my arm and hand but only the right side. I got the vaccine on my left arm.. I also had diarrhea ,  body ache and fatigue for several days.
I was unable to lift my arm for normal daily ADL's. I was put on 3 rounds of steroids and called into work in between the doses. It was all under workmans competition. Yet I was fired due to calling in. I was caused great pain, and discomfort for over 6 months. Getting dressed and sleeping became impossible. I still have tingling in my hand from time to time. And discomfort lifting certain ways. My arm now clicks with movement.
ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 4/17/2023 CEREBRAL EMBOLISM
Started to feel like I had post nasal drip and a cough, and achy with a headache. Took home test - positive. Had a virtual appt. the next day. Was given PAXLOVID. Took as prescribed, after the 5 day course I started feeling a lot better, except on the 4th day I started getting really tired again.
CHILD HAS 3 SMALL POXS AROUND THE SITE OF INJECTION OF THE VARICELLA VACCINE.
Patient received her 2nd Booster prior to the recommended 4 month interval. Patient had COVID vaccinations 1/14/21 Moderna, 2/4/21 Moderna, 12/8/21 Moderna (invalid dose, repeat vaccination required), 5/4/22 Pfizer, and 7/28/22 Moderna. Per CDC guidance, no repeat booster is recommended. Patient was informed of this. No negative effects were seen.